Abstract
The protective function of the pineal hormone melatonin in the etiology of cancer and carcinogenic activation is increasingly well-established. Low melatonin levels seem to parallel cancer growth. The question arises as to which factors cause the depression of melatonin levels and what the direct effects are. Melatonin is known to be metabolized in the liver by hydroxylation and subsequent conjugation yielding 6-sulfatoxymelatonin as a main product. Nevertheless, the microsomal monoxygenases catalyzing the first step have been poorly investigated. To further characterize these enzymes, typical inducers of three different sub-classes, namely phenobarbital, 7,12-dimethylbenz[a]anthracene, and 17β-estradiol, were administered to female Fischer rats. Circadian urinary excretion patterns of melatonin and 6-sulfatoxymelatonin were determined over a 24-hour period on the third (second) day of induction. Liver homogenates were used to monitor the in vitro conversion of melatonin or 6-hydroxymelatonin to 6-sulfatoxymelatonin. Results of both approaches showed the microsomal monoxygenases catalyzing the 6-hydroxylation of melatonin to be strongly inducible by phenobarbital and to a lesser degree by the polyaromatic hydrocarbon 7,12-dimethylbenz[a]anthracene. The dramatic depletion of circulating melatonin as a result of these induction patterns and its possible implications for oncogenesis are discussed.
Similar content being viewed by others
References
Bartsch, C., Bartsch, H., Jain, A. K., Laumas, K. R., and Wetterberg, L., J. neural transm.52 (1981) 281.
Tamarkin, L., Danforth, D., Lichter, A., DeMoss, E., Cohen, M., Chabner, B., and Lippman, M., Science216 (1982) 1003.
Bartsch, C., Bartsch, H., Fuchs, U., Lippert, T. H., Bellmann, O., and Gupta, D., Cancer64 (1989) 426.
Tamarkin, L., Cohen, M., Roselle, D., Reichert, C., Lippman, M., and Chabner, B., Cancer Res.41 (1981) 4432.
Aubert, C., Janiaud, P., and Lecalvez, J., J. neural Transm.47 (1980) 121.
Kopin, I. J., Pare, C. M. B., Axelrod, J., and Weissbach, H., J. biol. Chem.236 (1961) 3072.
Kveder, S., and Mclsaac, W. M., J. biol. Chem.236 (1961) 3214.
Jones, R. L., McGeer, P. L., and Greiner, A. C., Clinica. chim. Acta26 (1969) 281.
Young, I. M., Leone, R. M., Francis, P., Stovell, P. and Silman, R. E., J. clin. Endocr. Metab.60 (1985) 114.
Vakkuri, O., Tervo, J., Luttinen, R., Ruotsalainen, H., Rahkamaa, E., and Leppäluoto, J., Endocrinology120 (1987) 2453.
Weinberg, U., and Gasparini, F. J., in: Melatonin Rhythm Generating System. Int Symp, Bethesda, MD, 1981, p. 193. Ed. D. C. Klein. Karger, Basel 1982.
Bartsch, C., Bartsch, H., Lippert, T. H., and Gupta, D., Neuroendocrinology52 (1990) 538.
Breskvar, K., Steroids48 (1986) 85.
Arendt, J., Bojkowski, C., Franey, C., Wright, J., and Marks, V., J. clin. Endocr. Metab.60 (1985) 1166.
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., J. biol. Chem.193 (1951) 265.
Wetterberg, L., Eriksson, O., Friberg, Y., and Vangbo, B., Clinica chim. Acta86 (1978) 169.
Aldous, M. E., and Arendt, J., Ann. clin. Biochem.25 (1988) 298.
Sachs, L., Applied Statistics: A Handbook of Techniques. Springer, New York 1984.
Nelson, W., Tong, Y. L., Lee, J.-K., and Halberg, F., Chronobiologia6 (1979) 305.
Nebert, D. W., and Gonzalez, F. J., A. Rev. Biochem.56 (1987) 945.
Ozaki, Y., Wurtman, R. J., Alonso, R., and Lynch, H. J., Proc. natl Acad. Sci. USA75 (1978) 531.
Okey, A. B., Pharmac. Ther.45 (1990) 241.
Gonzalez, F. J., Pharmac. Ther.45 (1990) 1.
Nelson, D. R., Kamataki, T., Waxman, D. J. Guengerich, F. P., Estabrook, R. W., Feyereisen, R., Gonzalez, F. J., Coon, M. J., Gunsalus, I. C., Gotoh, O., Okuda, K., and Nebert, D. W., DNA Cell Biol.12 (1993) 1.
Ryan, D. E. and Levin, W., Pharmac. Ther.45 (1990) 153.
Wrighton, S. A., and Stevens, J. C., Crit. Rev. Toxic.22 (1992) 1.
Kimura, S., Kozak, C. A., and Gonzalez, F. J., Biochemistry28 (1989) 3798.
Ianăş, O., Olinescu, R., and Bădescu, I., Rom. J. Endocr.29 (1991) 147.
Poeggeler, B., Reiter, R. J., Tan, D.-X., Chen, L.-D., and Manchester, L. C., J. pineal Res.14 (1993) 151.
Reiter, R. J., Poeggeler, B., Tan, D.-X., Chen, L.-D., Manchester, L. C., and Guerrero, J. M., Neuroendocr. Lett.15 (1993) 103.
Reiter, R. J., Braz. J. med. biol. Res.26 (1993) 1141.
Menendez-Pelaez, A., Poeggeler, B., Reiter, R. J., Barlow-Walden, L., Pablos, M. I., and Tan, D.-X., J. cell. Biochem.53 (1993) 373.
Frenkel, K., Pharmac. Ther.53 (1992) 127.
Tan, D.-X., Poeggeler, B., Reiter, R. J., Chen, L.-D., Chen, S., Manchester, L. C., and Barlow-Walden, L. R., Cancer Lett.70 (1993) 65.
Kothari, L., and Subramanian, A., Anti-Cancer Drugs3 (1992) 623.
Bartsch, C., Praast, G., Peters, C., Bartsch, H., Mecke, D., and Lippert, T. H., in: Melatonin and the Pineal Gland —From Basic Science to Clinical Application, p. 317. Eds Y. Touitou, J. Arendt and P. Pévet. Elsevier Science Publishers B.V., Amsterdam 1993.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Praast, G., Bartsch, C., Bartsch, H. et al. Hepatic hydroxylation of melatonin in the rat is induced by phenobarbital and 7,12-dimethylbenzy[a]anthracene — implications for cancer etiology. Experientia 51, 349–355 (1995). https://doi.org/10.1007/BF01928893
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01928893